Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cerus Corp (CERS)

Cerus Corp (CERS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 359,362
  • Shares Outstanding, K 192,172
  • Annual Sales, $ 233,800 K
  • Annual Income, $ -15,630 K
  • EBIT $ -9 M
  • EBITDA $ -7 M
  • 60-Month Beta 1.63
  • Price/Sales 1.70
  • Price/Cash Flow N/A
  • Price/Book 5.38

Options Overview Details

View History
  • Implied Volatility 200.70% (+79.85%)
  • Historical Volatility 79.84%
  • IV Percentile 57%
  • IV Rank 28.71%
  • IV High 588.50% on 04/10/25
  • IV Low 44.51% on 06/06/25
  • Expected Move (DTE 15) 0.2380 (12.83%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 597
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 6,207
  • Open Int (30-Day) 5,555
  • Expected Range 1.6170 to 2.0930

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.03
  • Number of Estimates 1
  • High Estimate $-0.03
  • Low Estimate $-0.03
  • Prior Year $-0.04
  • Growth Rate Est. (year over year) +25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6200 +14.81%
on 03/12/26
2.3000 -19.13%
on 03/04/26
-0.6700 (-26.48%)
since 03/02/26
3-Month
1.6200 +14.81%
on 03/12/26
2.9550 -37.06%
on 01/14/26
-0.1100 (-5.58%)
since 01/02/26
52-Week
1.1200 +66.07%
on 04/07/25
2.9550 -37.06%
on 01/14/26
+0.4600 (+32.86%)
since 04/02/25

Most Recent Stories

More News
Cerus Appoints Vivek Jayaraman as President and Chief Executive Officer

William “Obi” Greenman to become Executive Chairman Leadership changes to take effect July 1, 2026

CERS : 1.8600 (-0.53%)
Cathie Wood Bets $19 Million on 5 Beaten-Down Stocks

Cathie Woods’s ARK Invest deploys $19 million across five growth stocks in this uncertain market.

DKNG : 23.16 (+4.51%)
ARKF : 38.07 (+0.34%)
CMPS : 5.79 (+3.02%)
ARKW : 121.60 (+0.26%)
ARKG : 27.36 (+1.00%)
CNTN : 3.26 (+0.62%)
CERS : 1.8600 (-0.53%)
HOOD : 68.90 (-1.73%)
ARKK : 68.56 (+0.23%)
Cerus: Q4 Earnings Snapshot

Cerus: Q4 Earnings Snapshot

CERS : 1.8600 (-0.53%)
Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results

2025 Total Revenue of $233.8 million, up 16% from 2024; 2025 Product Revenue of $206.1 million, up 14% from 2024 Strengthened Financial Foundation Through Strong Commercial...

CERS : 1.8600 (-0.53%)
Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference

Cerus Corporation (Nasdaq: CERS) announced today that members of the Company’s management are scheduled to present at the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026, at 10:30...

CERS : 1.8600 (-0.53%)
Cerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026

Cerus Corporation (Nasdaq: CERS) announced today its fourth quarter and full-year 2025 financial results will be released on Monday, March 2, 2026, after the close of the stock market. The Company will...

CERS : 1.8600 (-0.53%)
DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus’ INTERCEPT™ Blood System in Routine Clinical Practice

Cerus Corporation (Nasdaq: CERS) today announced the start of the INITIATE study by the German Red Cross Blood Donation Service Baden-Württemberg – Hessen and its subsidiary organization, the German...

CERS : 1.8600 (-0.53%)
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook

Preliminary Full-Year 2025 Product Revenue of $206.1 Million Full-Year 2026 Product Revenue Expected to be $224 Million to $228 Million, Reflecting 9%-11% Growth, Year-Over-Year...

CERS : 1.8600 (-0.53%)
Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America

Cerus Corporation (Nasdaq: CERS) announced today that it has entered into a group purchasing agreement with Blood Centers of America (BCA), the largest blood supply cooperative in the U.S. BCA member blood...

CERS : 1.8600 (-0.53%)
Cerus: Q3 Earnings Snapshot

Cerus: Q3 Earnings Snapshot

CERS : 1.8600 (-0.53%)

Business Summary

Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company...

See More

Key Turning Points

3rd Resistance Point 1.9983
2nd Resistance Point 1.9567
1st Resistance Point 1.9133
Last Price 1.8600
1st Support Level 1.8283
2nd Support Level 1.7867
3rd Support Level 1.7433

See More

52-Week High 2.9550
Fibonacci 61.8% 2.2540
Fibonacci 50% 2.0375
Last Price 1.8600
Fibonacci 38.2% 1.8210
52-Week Low 1.1200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.